A new study found that fair prices for medications like Wegovy and Zepbound would be hundreds less per month than they are ...

Regeneron Pharmaceuticals, Inc. faces Eylea revenue decline but shows growth potential with Dupixent & Libtayo. Click for ...

This interactive map explains where COPD rates, hospitalizations, and deaths are highest across the United States.

For current and former smokers, statins may reduce the amount of chest muscle loss, while aspirin may contribute to increased ...

For current and former smokers, statins may reduce the amount of chest muscle loss, while aspirin may contribute to increased chest muscle loss, according to a new study.

Despite early success, Verona's lack of specific 2025 guidance and competition from Dupixent and other drugs raise concerns.

With 30% of COPD cases misdiagnosed, experts call for improved diagnostic strategies, better disease classification, and ...

The risk for moderate or severe COPD exacerbation was lower among those treated with SGLT-2is and with GLP-1 RAs versus DPP-4is.

Young COPD, referring to cases of COPD that occur in people aged 20–50 years, is often overlooked in research and clinical ...

SGLT2 inhibitors and GLP-1RAs yielded lower risks for COPD exacerbation than DPP-4 inhibitors among patients with type 2 diabetes.

chronic obstructive pulmonary disease (COPD), and patients who have received a lung transplant. It ...